A lawsuit with a $289-million payout had a daunting affect on Bayer stock, which plunged 10% on Monday after the California jury trial ended late last week. Attorneys claimed Monsanto's weedkiller
Roundup caused terminal cancer in a groundskeeper who used it 20 to 30 times a year. "The stock drop sent a cautionary signal to the company that acquired Monsanto, the maker of the weedkiller, in
June for $63 billion," according to
The Washington Post. "Bayer had previously
announced that the Monsanto brand name would be nixed as soon as this month."
Read the whole story at The Washington Post »
